Advertisement

ADVERTISEMENT

Structural heart disease

Suggested Technique
The Peri-Close Technique: A Novel Method for the Closure of Large-Bore Arterial Access
02/01/2019

David J. Luke, MD, Joseph A. Walsh, MD, David V. Daniels, MD, Sutter Health Cardiology, San Francisco, California

David J. Luke, MD, Joseph A. Walsh, M...
The peri-close technique for percutaneous closure of large-bore access is the primary closure technique for structural heart and peripheral ECMO cases at our institution. This technique is simple, and utilizes a device that is both well known...
The peri-close technique for percutaneous closure of large-bore access is the primary closure technique for structural heart and peripheral ECMO cases at our institution. This technique is simple, and utilizes a device that is both well known...
The peri-close technique for...
02/01/2019
Cath Lab Digest
Clinical Images
Single Leaflet Device Attachment Complicating Percutaneous Edge-to-Edge Repair of the Tricuspid Valve Using the MitraClip
10/07/2018

Chak-Yu So, MBChB;  Kun-Chong Tam, MD;  Yat-Yin Lam, MD;  Alex Pui-Wai Lee, MD

Chak-Yu So, MBChB;  Kun-Chong Tam, MD...
We demonstrate that immediate deployment of one or more adjacent clips, particularly to the remaining attached leaflet, may stabilize the flailing clip and be a possible transcatheter treatment option for single leaflet device attachment...
We demonstrate that immediate deployment of one or more adjacent clips, particularly to the remaining attached leaflet, may stabilize the flailing clip and be a possible transcatheter treatment option for single leaflet device attachment...
We demonstrate that immediate...
10/07/2018
Cath Lab Digest
News
News: COAPT Trial Shows Treatment With MitraClip is Superior to Medical Therapy for Advanced Heart Failure Patients with Significant Secondary Mitral Regurgitation
10/03/2018
The COAPT trial met both the primary safety and efficacy endpoints and all secondary endpoints, including reducing all-cause mortality through two years.
The COAPT trial met both the primary safety and efficacy endpoints and all secondary endpoints, including reducing all-cause mortality through two years.
The COAPT trial met both the...
10/03/2018
Cath Lab Digest
Use of the ACIST CVi System in Structural Heart Interventions: Efficiency and Image Quality for Different Contrast Injection Needs
05/29/2018

Cath Lab Digest talks with Creighton Don, MD, PhD, Associate Professor of Medicine, Attending Physician, University of Washington Medical Center, Seattle, Washington. 

Cath Lab Digest talks with Creighton ...
Because the ACIST offers higher flows in certain circumstances, such as when there is a very high-flow state, the system allows you to get a better injection than with a hand injection.
Because the ACIST offers higher flows in certain circumstances, such as when there is a very high-flow state, the system allows you to get a better injection than with a hand injection.
Because the ACIST offers higher...
05/29/2018
Cath Lab Digest
The Best ACIST-ant in the Cath Lab: How the CVi Power Injector System was Used to Treat a Complex TAVR Patient
05/29/2018

Sandeep Krishnan, MD, Mario Ramos, RT(R), Creighton Don, MD, University of Washington Medical Center, Seattle, Washington

Sandeep Krishnan, MD, Mario Ramos, RT...
This case highlights the versatility of the ACIST CVi contrast injection system to navigate the various challenges of complex anatomy. We were able to transition seamlessly from an aortic arch angiogram, to an aortic root angiogram, to...
This case highlights the versatility of the ACIST CVi contrast injection system to navigate the various challenges of complex anatomy. We were able to transition seamlessly from an aortic arch angiogram, to an aortic root angiogram, to...
This case highlights the...
05/29/2018
Cath Lab Digest
Cath Lab Spotlight
Spotlight: Boulder Community Health
12/28/2017

Julie Jenkins, BSN, RN, Cath Lab/EP Lab/CVC/Echo Manager, Boulder, Colorado

 

Julie Jenkins, BSN, RN, Cath Lab/EP L...
The structural heart program started in October 2017 with TAVRs and balloon aortic valvuloplasties. We were fortunate to bring in a highly experienced structural heart medical director to start the program, so the program’s implementation has...
The structural heart program started in October 2017 with TAVRs and balloon aortic valvuloplasties. We were fortunate to bring in a highly experienced structural heart medical director to start the program, so the program’s implementation has...
The structural heart program...
12/28/2017
Cath Lab Digest
Cath Lab Spotlight
Spotlight: Boulder Community Health
12/28/2017

Julie Jenkins, BSN, RN, Cath Lab/EP Lab/CVC/Echo Manager, Boulder, Colorado

 

Julie Jenkins, BSN, RN, Cath Lab/EP L...
The structural heart program started in October 2017 with TAVRs and balloon aortic valvuloplasties. We were fortunate to bring in a highly experienced structural heart medical director to start the program, so the program’s implementation has...
The structural heart program started in October 2017 with TAVRs and balloon aortic valvuloplasties. We were fortunate to bring in a highly experienced structural heart medical director to start the program, so the program’s implementation has...
The structural heart program...
12/28/2017
Cath Lab Digest
Clinical News
News: Medtronic Receives FDA Approval for CoreValve Evolut Pro Transcatheter Valve with Advanced Sealing
04/09/2017
The Evolut PRO device features a unique valve design with an outer wrap that adds surface area contact between the valve and the native aortic annulus to further advance valve sealing performance. The biocompatible porcine pericardial tissue...
The Evolut PRO device features a unique valve design with an outer wrap that adds surface area contact between the valve and the native aortic annulus to further advance valve sealing performance. The biocompatible porcine pericardial tissue...
The Evolut PRO device features a...
04/09/2017
Cath Lab Digest
Clinical News
News: Boston Scientific Announces Agreement to Acquire Symetis
04/09/2017
The Symetis portfolio includes the ACURATE TA and ACURATE neo/TF valve* systems for use in the treatment of high-risk patients suffering from severe and symptomatic aortic valve stenosis, which are sold in Europe and in other geographies...
The Symetis portfolio includes the ACURATE TA and ACURATE neo/TF valve* systems for use in the treatment of high-risk patients suffering from severe and symptomatic aortic valve stenosis, which are sold in Europe and in other geographies...
The Symetis portfolio includes...
04/09/2017
Cath Lab Digest
Case Report
Transcatheter Management of Post Infarction Ventricular Septal Rupture With Concomitant Percutaneous Coronary Intervention
09/05/2016

Khalid Amber, FACC, FSCAI, FESC, Hussein A. Alsalkhi, MD, Ahmed N. Rajeeb, MD, Najaf Cardiac Center, An Najaf, Iraq

Khalid Amber, FACC, FSCAI, FESC, Huss...
Ventricular septal defect (VSD) or rupture (VSR) after acute myocardial infarction is an uncommon but catastrophic event with poor prognosis. Immediate surgical closure with hemodynamic support (such as an intra-aortic balloon pump or IABP)...
Ventricular septal defect (VSD) or rupture (VSR) after acute myocardial infarction is an uncommon but catastrophic event with poor prognosis. Immediate surgical closure with hemodynamic support (such as an intra-aortic balloon pump or IABP)...
Ventricular septal defect (VSD)...
09/05/2016
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use